Inventor · disambiguated record
Vadim Dudkin
Also filed as: DUDKIN VADIM · DUDKIN VADIM Y
23 granted patents·15 pending applications·92 citations·filing 2005–2025
94Inventor score
Files withJANSSEN BIOTECH INC13SIRNA THERAPEUTICS INC7FLAGSHIP PIONEERING INNOVATIONS VI LLC4ARRINGTON KENNETH L3DUDKIN VADIM Y2
Top patents by PatentIndex Score
38 records- 0197US11576986B2Macrocyclic chelators and methods of use thereofJANSSEN BIOTECH INC·Filed 2020·Granted Feb 14, 2023·9 cites·22 claims
- 0293US12338474B2Compositions and methods for producing circular polyribonucleotidesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Granted Jun 24, 2025·1 cites·23 claims
- 0390US8765784B2Positive allosteric modulators of MGLUR2ARRINGTON KENNETH L·Filed 2011·Granted Jul 1, 2014·20 cites·19 claims
- 0488US11117917B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2019·Granted Sep 14, 2021·2 cites·20 claims
- 0588US7645454B2Prostate specific antigens and uses thereofSLOAN KETTERING INST CANCER·Filed 2005·Granted Jan 12, 2010·11 cites·23 claims
- 0688US7501435B2Inhibitors of checkpoint kinasesMERCK & CO INC·Filed 2007·Granted Mar 10, 2009·8 cites·5 claims
- 0787US7531181B2Gp120 specific antigens and uses thereofSLOAN KETTERING INST CANCER·Filed 2005·Granted May 12, 2009·15 cites·45 claims
- 0886US9540639B2Tetragalnac containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2013·Granted Jan 10, 2017·10 cites·22 claims
- 0984US10221205B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Granted Mar 5, 2019·3 cites·20 claims
- 1084US9655976B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2013·Granted May 23, 2017·6 cites·35 claims
- 1178US2024391849A1Radiolabeling of polypeptidesJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 1277US12304925B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2021·Granted May 20, 2025·0 cites·20 claims
- 1375US9062059B2Pyrimidine PDE10 inhibitorsCOX CHRISTOPHER D·Filed 2012·Granted Jun 23, 2015·3 cites·37 claims
- 1475US2025188187A1Site-specific conjugation of glycosylated monoclonal antibodies with transglutaminaseJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 1575US2025206844A1Site-specific conjugation of glycosylated monoclonal antibodies with transglutaminaseJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 1674US2024238461A1Macrocyclic compounds and methods of use thereofJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1773US12453785B2Macrocyclic chelators and methods of use thereofJANSSEN BIOTECH INC·Filed 2022·Granted Oct 28, 2025·0 cites·18 claims
- 1871US8785481B2Ether benzotriazole derivativesBESHORE DOUGLAS C·Filed 2011·Granted Jul 22, 2014·2 cites·13 claims
- 1971US2025277224A1Compositions and methods for producing circular polyribonucleotidesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2025·Application pending·0 cites
- 2070US2024384002A1METHODS FOR SITE SPECIFIC CONJUGATION OF PROTEINS CONTAINING GLYCOSYLATED Fc DOMAINSJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 2168US8975286B2Ether benzotriazole derivativesDUDKIN VADIM Y·Filed 2010·Granted Mar 10, 2015·1 cites·18 claims
- 2267US9840531B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Granted Dec 12, 2017·0 cites·21 claims
- 2367US2025171379A1Radiolabeling of polypeptidesJANSSEN BIOTECH INC·Filed 2025·Application pending·0 cites
- 2466US12227593B2Site-specific conjugation of glycosylated monoclonal antibodies with transglutaminaseJANSSEN BIOTECH INC·Filed 2021·Granted Feb 18, 2025·0 cites·45 claims
- 2566US8993779B2Positive allosteric modulators of MGLUR2DUDKIN VADIM Y·Filed 2011·Granted Mar 31, 2015·1 cites·9 claims
- 2666US2022143231A1Macrocyclic compounds and methods of use thereofJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 2764US2025051386A1Compositions and methods for purifying polyribonucleotidesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 2864US2024417714A1Compositions and methods for purifying polyribonucleotidesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 2962US12240790B2Radiolabeling of polypeptidesJANSSEN BIOTECH INC·Filed 2018·Granted Mar 4, 2025·0 cites·23 claims
- 3059US12084475B2Methods for site specific conjugation of proteins containing glycosylated Fc domainsJANSSEN BIOTECH INC·Filed 2021·Granted Sep 10, 2024·0 cites·17 claims
- 3151US9428492B2Secondary alcohol substituted triazoles as PDE10 inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Aug 30, 2016·0 cites·16 claims
- 3247US2019184028A1Targeting with firbronectin type iii like domain moleculesJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 3346US10214742B2Tetragalnac containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2016·Granted Feb 26, 2019·0 cites·20 claims
- 3442US2011014226A1high throughput protein interaction assayCAULFIELD MICHAEL J·Filed 2009·Application pending·0 cites
- 3541US9200001B2Triazolyl PDE10 inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted Dec 1, 2015·0 cites·16 claims
- 3640US2009258852A1Inhibitors of Checkpoint KinasesARRINGTON KENNETH L·Filed 2006·Application pending·0 cites
- 3737US2009233896A1Inhibitors of checkpoint kinasesARRINGTON KENNETH L·Filed 2006·Application pending·0 cites
- 3835US2013203756A1Isoindoline pde10 inhibitorsBUNDA JAMIE L·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →